The move marks a rare action by the FDA to sanction a study on cannabis despite the plant’s current Schedule I classification under federal law as a drug with no therapeutic use, in the same bucket as ...
The Multidisciplinary Association for Psychedelic Studies (MAPS) said this week the U.S. Food and Drug Administration approved a study of the therapeutic value of cannabis on 320 veterans with ...